No, like you said, you can't assume $100K per person worldwide because many of these cases will be in poor countries, and most of these people will not seek treatment, or they will seek alternative cheaper treatment which of course wouldn't work so well. Point is it is difficult to get a reliable count outside of USA (except for Europe and developed countries in Asia). Many people in these poor countries simply won't have the money. But here in the USA, most people will seek treatment. And the number is correct, 12,200 new cases each year. Of course not all these people would use ADXS's drugs. A certain number of them will use other drugs because after all there is competition and not all doctors will recommend ADXS drugs. So can't expect ALL 12,200 cases to go to ADXS. But still, let's say half do. At $100,000 per case that's $610M revenue. (Of course ADXS wouldn't get all that revenue. A good deal of the cost will go to the medical facilities, doctors, various assistants, etc.) In fact, most of it will go there. I don't know that ADXS has given any estimated prices for their drugs. It could be around $20K per patient for the drug alone. That's a WAG. I had a coworker 20 years ago whose wife died from cancer. The total treatment cost then was $100K. So i have to guess 20 years later the cost will be much higher. And when you count Europe and developed Asia, there will be a lot more revenue. AND, we're only talking cervical cancer. ADXS drugs will help other cancer types too which will bring in much more revenue.
News 
Market Data 
Discover 
AI
